Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05546190 · ClinicalTrials.gov registry record
A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 25
- Enrollment target
NCT05546190 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 25 participants.
The verdict
NCT05546190 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The participants of this study will have AUL spasticity and have a need for botulinum toxin type A injections. AUL spasticity is where people develop tightening or stiffness of the muscles in the arms. Botulinum toxin type A is used for the treatment of spasticity in addition to physiotherapy. This study will ask participants to describe their experience living with AUL spasticity. This information will be used to assess the Arm Activity Measure (ArmA). ArmA is a scale designed to assess upper limb function in people with AUL spasticity. This study could suggest changes to the ArmA to improve its suitability for people with AUL spasticity or even the development of a new scale.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-09-20 |
| Est. Completion | 2023-03-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05546190
The ClinicalTrials.gov registry entry for NCT05546190 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05546190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05546190 about?
NCT05546190 is a clinical study titled "A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)". The participants of this study will have AUL spasticity and have a need for botulinum toxin type A injections. AUL spasticity is where people develop tightening or stiffness of the muscles in the arms. Botulinum toxin type A is used for the treatment of spasticity in addition to physiotherapy. This ...
What is the current status of trial NCT05546190?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2022-09-20. Estimated completion is 2023-03-23.
Who is sponsoring clinical trial NCT05546190?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.